Vir Biotechnology, Inc. (NASDAQ: VIR) Stock Information | RedChip

Vir Biotechnology, Inc. (NASDAQ: VIR)


$7.5800
-0.0200 ( -0.26% ) 105.1K

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Market Data


Open


$7.5800

Previous close


$7.6000

Volume


105.1K

Market cap


$1.04B

Day range


$7.4850 - $7.6950

52 week range


$7.1200 - $13.0900

SEC Filings


Form Type Description Pages Date
ars Annual reports 1 Apr 19, 2024
def Proxies and info statements 21 Apr 19, 2024
8-k 8K-related 15 Apr 18, 2024
4 Insider transactions 1 Apr 04, 2024
4 Insider transactions 1 Apr 02, 2024
4 Insider transactions 1 Mar 28, 2024
4 Insider transactions 1 Feb 26, 2024
4 Insider transactions 1 Feb 26, 2024
4 Insider transactions 1 Feb 26, 2024
4 Insider transactions 1 Feb 26, 2024

Latest News